# Additional Sequencing Cohorts for the Alzheimer's Disease Sequencing Project

> **NIH NIH U01** · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2021 · $1,758,467

## Abstract

PROJECT SUMMARY
 The Alzheimer's Disease Sequencing Project (ADSP) is a national sequencing initiative focused on
identifying genetic risk and protective factors for AD. The projects' discovery phase includes whole exome
sequencing (WES) of 10,061 unrelated non-White Hispanic (NHW) cases (N=5,096) and controls (N=4,965),
and whole genome sequencing (WGS) of 584 NHW and Hispanic familial samples. The 'Discovery Extension
Phase' of the project added WGS on ~430 additional familial samples. An initial 'Follow-Up Study (FUS)'
Phase focused on examining candidate variants from the discovery phase, and identification of novel variants
through combined analysis of diverse datasets is ongoing and focuses on additional existing cohorts with
unrelated AD cases that 'encompass the richest possible ethnic diversity' as well as highly valuable set of
autopsy confirmed cases and controls. In total we have already included in FUS over 14000 samples for
sequencing including >2800 autopsy confirmed cases and controls, >6800 Hispanic (HI) cases and controls
and > 5790 African American (AA) cases and controls. In this FUS2 application, we are proposing sequencing
of an additional 4243 samples that will both increase our power to find effects but will also enhance our
analysis by inclusion of several rich and unique sample sets. Additionally, these datasets will become an
invaluable resource for the AD research community at-large.
 In summary ADSP will provide large ethnically diverse as well as unique datasets for both
validation and generalization of ADSP discovery phase findings and discovery of novel risk and
protective variants/genes for late onset AD (LOAD). Additionally, these datasets will become an invaluable
resource for the AD research community at-large. Specifically we propose to: 1. Increase the diversity and
further enrich the clinical phenotype data of the ADSP including data sets targeted to find protective effects
through assembling samples from existing cohorts from unique populations that fulfill this goal. 2.
Collaborate with the National Cell Repository for AD (NCRAD) in assembling DNA, blood and brain tissue on
these existing cohorts, which will serve as a central resource for the AD research community. 3. Generate
genome-wide SNP array data through the John P. Hussman Institute (HIHG) Center for Genome
Technology (CGT) and whole genome sequencing data through the Uniformed Services University of the
Health Sciences (USUHS) for all collected samples 4. Collaborate with NIA Genetics of AD Data Storage
Site (NIAGADS), the Genome Center for AD (GCAD) and the University of Pennsylvania and the HIHG
Center for Genetic Epidemiology and Statistical Genetics Quality Control Teams in processing, storage and
dissemination of final data sets. Our overall goal is to enhance the discovery of AD risk and protective
factors by facilitating research on AD in ethnically diverse and phenotypically rich datasets.

## Key facts

- **NIH application ID:** 10241931
- **Project number:** 5U01AG062943-03
- **Recipient organization:** UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
- **Principal Investigator:** RICHARD P MAYEUX
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,758,467
- **Award type:** 5
- **Project period:** 2019-09-01 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10241931

## Citation

> US National Institutes of Health, RePORTER application 10241931, Additional Sequencing Cohorts for the Alzheimer's Disease Sequencing Project (5U01AG062943-03). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10241931. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*